Ultralife Corp. (ULBI) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ULBI Hot Sheet
Price: $7.01 +2.34%
Financial Fact:
Net (income) loss attributable to noncontrolling interest: 3K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net (income) loss attributable to noncontrolling interest: 3K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.07, $0.06 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $51 million.
For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- enVVeno Medical (NVNO) files $100M mixed shelf
- QSE closes $6M private placement with final tranche of $674K
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
